BioCentury
ARTICLE | Clinical News

VivaGel astodrimer sodium: SPA received

July 28, 2014 7:00 AM UTC

Starpharma said it received an SPA from FDA for a pair of identical, double-blind, placebo-controlled, international Phase III trials to evaluate 1% VivaGel for 16 weeks each in about 600 women. On Ju...